AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Corrections.

OB GYN News

| June 15, 2003 | COPYRIGHT 2003 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

In "Fondaparinux May Match Heparins for VTE Treatment" (March 15, 2003, p. 29), the outcome measure rate of recurrent venous thromboembolic events" was incorrectly cited in both studies as "death rate."

In ...

Related articles from newspapers, magazines, journals, and more
Fondaparinux may match heparins for VTE treatment. (Synthetic Anticoagulant).
Magazine article from: OB GYN News Zoler, Mitchel L. March 15, 2003 700+ words
PHILADELPHIA -- Fondaparinux, a synthetic anticoagulant, appears to be as safe and effective as a low-molecular-weight heparin or unfractionated heparin for the initial treatment of symptomatic venous thromboembolism, Dr. Harry R. Buller said at the annual meeting of the American Society of
Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with...
Press release article from: PR Newswire December 10, 2007 700+ words
...direct medical costs associated with VTE treatment are reduced by $550 per patient when...related readmission rates of these VTE treatment regimens are not clear. A retrospective...direct medical costs associated with VTE treatment (including drug costs, hospital costs...
/C O R R E C T I O N -- sanofi-aventis/.
Press release article from: PR Newswire December 10, 2007 700+ words
...Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractioned Heparin (UFH)," issued earlier...Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)," rather than...
Scientists at Brigham and Women's Hospital target thromboembolism.
Newspaper article from: Blood Weekly October 9, 2008 700+ words
...surgical and medical patients and in adherence to guidelines for VTE treatment. The heterogeneity of the patient population at risk for...awareness, ensure VTE prophylaxis, and recommend appropriate VTE treatment can have a favorable clinical and economic impact." Fanikos...
Studies conducted at Tianjin University on ceramics recently published.
Newspaper article from: Journal of Technology September 1, 2009 700+ words
...of Er metal followed by vapor transport equilibration (VTE) treatment under three different conditions of 1135 degrees C/22 h...LiNbO3 Crystals Prepared by Standard Er Diffusion and Post-VTE Treatment. Journal of the American Ceramic Society, 2009;92(8...
Scientists at Thomas Jefferson University publish research in thromboembolism.
Newspaper article from: Blood Weekly August 7, 2008 700+ words
...economic burden in US hospitals. Clinical guidelines for acute VTE treatment recommend antithrombotic therapy (at least 5 days) with...inpatient medical costs associated with LMWH and UFH for acute VTE treatment. Furthermore, for both LMWH and UFH discharges, we compare...
Arixtra (Fondaparinux Sodium) Once Daily Demonstrates Benefit in Treating...
Press release article from: PR Newswire December 9, 2002 700+ words
...be effectively used for the initial treatment of both DVT and PE. The MATISSE trials provide the broadest evaluation of VTE treatment ever conducted with therapy administered either in-hospital or at home. Two MATISSE trials were conducted, MATISSE PE...
Study shows new pill can treat life-threatening DVT without complications of...
Press release article from: PR Newswire July 15, 2003 700+ words
...using INR. Ximelagatran does not require this kind of monitoring and is given at a fixed dose of 36 mg twice-a-day for VTE treatment in all patients. Treatment duration was six months. As part of the study protocol, liver enzymes were measured. The tests...
For more facts and information, see all results

Source: HighBeam Research, Corrections.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA